These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 39073860)
1. Regulatory Frameworks for AI-Enabled Medical Device Software in China: Comparative Analysis and Review of Implications for Global Manufacturer. Han Y; Ceross A; Bergmann J JMIR AI; 2024 Jul; 3():e46871. PubMed ID: 39073860 [TBL] [Abstract][Full Text] [Related]
2. Translating the regulatory landscape of medical devices to create fit-for-purpose artificial intelligence (AI) cytometry solutions. Bogdanoski G; Lucas F; Kern W; Czechowska K Cytometry B Clin Cytom; 2024 Jul; 106(4):294-307. PubMed ID: 38396223 [TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence in medical device software and high-risk medical devices - a review of definitions, expert recommendations and regulatory initiatives. Fraser AG; Biasin E; Bijnens B; Bruining N; Caiani EG; Cobbaert K; Davies RH; Gilbert SH; Hovestadt L; Kamenjasevic E; Kwade Z; McGauran G; O'Connor G; Vasey B; Rademakers FE Expert Rev Med Devices; 2023 Jun; 20(6):467-491. PubMed ID: 37157833 [TBL] [Abstract][Full Text] [Related]
4. Regulatory Aspects of Artificial Intelligence and Machine Learning. Pantanowitz L; Hanna M; Pantanowitz J; Lennerz J; Henricks WH; Shen P; Quinn B; Bennet S; Rashidi HH Mod Pathol; 2024 Sep; 37(12):100609. PubMed ID: 39260776 [TBL] [Abstract][Full Text] [Related]
5. Artificial Intelligence and Machine Learning Applied at the Point of Care. Angehrn Z; Haldna L; Zandvliet AS; Gil Berglund E; Zeeuw J; Amzal B; Cheung SYA; Polasek TM; Pfister M; Kerbusch T; Heckman NM Front Pharmacol; 2020; 11():759. PubMed ID: 32625083 [TBL] [Abstract][Full Text] [Related]
6. Methodology for Conducting Post-Marketing Surveillance of Software as a Medical Device Based on Artificial Intelligence Technologies. Zinchenko VV; Arzamasov KM; Chetverikov SF; Maltsev AV; Novik VP; Akhmad ES; Sharova DE; Andreychenko AE; Vladzymyrskyy AV; Morozov SP Sovrem Tekhnologii Med; 2022; 14(5):15-23. PubMed ID: 37181834 [TBL] [Abstract][Full Text] [Related]
7. AI in imaging: the regulatory landscape. Hill DLG Br J Radiol; 2024 Feb; 97(1155):483-491. PubMed ID: 38366148 [TBL] [Abstract][Full Text] [Related]
8. Advancing medical device regulatory reforms for innovation, translation and industry development in China. Song X; Hu M; Li B; Zhang K; Zhang X; Wang L J Orthop Translat; 2022 Nov; 37():89-93. PubMed ID: 36262965 [TBL] [Abstract][Full Text] [Related]
9. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software. Woo JH; Kim EC; Kim SM Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755 [TBL] [Abstract][Full Text] [Related]
10. A comparative study of medical device regulation between countries based on their economies. Chettri B; Ravi R Expert Rev Med Devices; 2024 Jun; ():1-12. PubMed ID: 38832832 [TBL] [Abstract][Full Text] [Related]
11. Global Regulatory Frameworks for the Use of Artificial Intelligence (AI) in the Healthcare Services Sector. Palaniappan K; Lin EYT; Vogel S Healthcare (Basel); 2024 Feb; 12(5):. PubMed ID: 38470673 [TBL] [Abstract][Full Text] [Related]
12. Regulatory considerations for medical imaging AI/ML devices in the United States: concepts and challenges. Petrick N; Chen W; Delfino JG; Gallas BD; Kang Y; Krainak D; Sahiner B; Samala RK J Med Imaging (Bellingham); 2023 Sep; 10(5):051804. PubMed ID: 37361549 [TBL] [Abstract][Full Text] [Related]
14. AI as a Medical Device Adverse Event Reporting in Regulatory Databases: Protocol for a Systematic Review. Kale AU; Dattani R; Tabansi A; Hogg HDJ; Pearson R; Glocker B; Golder S; Waring J; Liu X; Moore DJ; Denniston AK JMIR Res Protoc; 2024 Jul; 13():e48156. PubMed ID: 38990628 [TBL] [Abstract][Full Text] [Related]
15. The EU medical device regulation: Implications for artificial intelligence-based medical device software in medical physics. Beckers R; Kwade Z; Zanca F Phys Med; 2021 Mar; 83():1-8. PubMed ID: 33657513 [TBL] [Abstract][Full Text] [Related]
16. The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use. Zhu S; Gilbert M; Chetty I; Siddiqui F Int J Med Inform; 2022 Sep; 165():104828. PubMed ID: 35780651 [TBL] [Abstract][Full Text] [Related]
17. Integrated Analytical Framework for the Development of Artificial Intelligence-Based Medical Devices. Arima H; Kano S Ther Innov Regul Sci; 2021 Jul; 55(4):853-865. PubMed ID: 33876397 [TBL] [Abstract][Full Text] [Related]
18. The Evolving Regulatory Paradigm of AI in MedTech: A Review of Perspectives and Where We Are Today. Zhou K; Gattinger G Ther Innov Regul Sci; 2024 May; 58(3):456-464. PubMed ID: 38528278 [TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence (AI) impacting diagnosis of glaucoma and understanding the regulatory aspects of AI-based software as medical device. Prabhakar B; Singh RK; Yadav KS Comput Med Imaging Graph; 2021 Jan; 87():101818. PubMed ID: 33307283 [TBL] [Abstract][Full Text] [Related]
20. Regulating AI-Based Medical Devices in Saudi Arabia: New Legal Paradigms in an Evolving Global Legal Order. Solaiman B Asian Bioeth Rev; 2024 Jul; 16(3):373-389. PubMed ID: 39022374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]